Keeping Stable Inflammatory Arthritis Patients in Their Communities With the Advanced Clinician Practitioner in Arthritis Care
NCT04249817 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-07-14
Summary
In Ontario, rheumatology services are in short supply. Many people with inflammatory arthritis (IA) are traveling long distances for care and face geographical/ financial challenges in so doing. Travel burden may be decreased and satisfaction with care improved by integrating existing health care resources. A few rheumatologists in Ontario have adopted a video conferencing (VC) model for follow-up of stable IA patients using the Ontario Telemedicine Network (OTN) with Extended Role Practitioners (ERPs) doing on-site assessments. Anecdotal evidence suggests this model benefits both patient and rheumatologist. We will determine how people with stable well-controlled IA, living more than 100 km round-trip from the rheumatology clinic, perceive quality of life before, during and after VC with ERP follow-up visits compared to usual care. Disease activity, functional status, medication adherence, patient satisfaction, and barriers to care will also be measured.
Conditions
- Inflammatory Arthritis
Interventions
- OTHER
-
Video Conferencing with Exteneded Role Practitioner (VC-ERP)
Participant goes to Ontario Telemedicine site for follow-up. At site, participant will get a physical assessment by an extended role practitioner and then will connect to their rheumatologist by videoconferencing for completion of follow-up.
Sponsors & Collaborators
-
Canadian Initiative for Outcomes in Rheumatology Care
collaborator OTHER -
Sunnybrook Health Sciences Centre
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-05
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- Canada
Study Locations
More Related Trials
-
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
NCT04973787 ·Status: UNKNOWN
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
NCT01209702 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
NCT01213017 ·Status: COMPLETED ·Phase: PHASE3
-
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
NCT01162421 ·Status: COMPLETED ·Phase: PHASE4
-
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
NCT02647762 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT01142726 ·Status: COMPLETED ·Phase: PHASE3
-
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
NCT02451748 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
NCT04870203 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate
NCT05121298 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis
NCT00424294 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
NCT00641225 ·Status: COMPLETED ·Phase: PHASE1
-
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00095147 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib
NCT03823378 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
NCT02222493 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
NCT03470688 ·Status: UNKNOWN
-
A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
NCT03178487 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Patients With Rheumatoid Arthritis
NCT00966875 ·Status: COMPLETED ·Phase: PHASE2
-
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
NCT02469753 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
NCT06754462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Bone MicroArchitecture Abatacept (BMA2)
NCT02675218 ·Status: TERMINATED
-
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
NCT00847613 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
NCT00439283 ·Status: COMPLETED ·Phase: PHASE3
-
REMission INDuction in Very Early Rheumatoid Arthritis
NCT02935387 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
NCT00160602 ·Status: COMPLETED ·Phase: PHASE3